DR. REDDY’S LABORATORIES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.
Dr. Reddy’s Laboratories Limited engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.
dr. reddy’s laboratories limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Generic. dr. reddy’s laboratories limited is SEBI Listed Company (India) and having:-
ISIN (An International Securities Identification Number): INE089A01023
Equity Stock (National Stock Exchange) Symbol: DRREDDY
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=DRREDDY
BSE Link IS: https://www.bseindia.com/stock-share-price/dr-reddys-laboratories-ltd/DRREDDY/500124/
Dr. Reddy’s Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Global Generics Segment (~80% of revenues) This is the main business of the company wherein it offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain.
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com For more information, log on to: www.drreddys.com
Dr. Reddy’s Laboratories stand with [We accelerate access to affordable and innovative medicines because Good Health Can’t Wait.]
Company Website: http://www.drreddys.com/
Company Website2: http://www.drreddys.com/
LinkedIn page URL: https://in.linkedin.com/company/dr–reddys-laboratories
Wiki Profile URL: https://en.wikipedia.org/wiki/Dr._Reddy’s_Laboratories
Popular Search Keywords: dr. reddy’s laboratories limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Generic industry
#dr #reddy’s #laboratories #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #generic #industry
